Fractional IP

Strategic, senior‑level IP guidance without the overhead of a full‑time hire

  • On‑demand, in‑house IP counsel with deep biotech and pharma expertise

  • Support across the full value chain, from early R&D through clinical development, regulatory milestones, commercial launch, and lifecycle management

  • Expert alignment of patent strategy with FDA/EMA regulatory exclusivities, including patent term extensions and market‑protection pathways

  • Embedded collaboration with scientific, clinical, and BD teams to bring real‑world business perspective to IP strategy

  • Practical, execution‑ready IP strategies that accelerate development and ensure capital readiness

  • Seamless work with internal leadership and a strong network of biotech investors and partners to align IP with growth, risk, and business strategy

  • 17+ years of in‑house experience, multiple FDA‑approved assets and SPC/PTE strategies including pædiatric extensions

  • Biotech and pharma companies often reach a point where IP decisions have major scientific, regulatory, and commercial consequences — but they don’t yet need (or can’t justify) a full‑time Head of IP. Fractional IP leadership fills this gap. It gives you seasoned, strategic guidance on the decisions that shape valuation, partnerships, exclusivity, and long‑term defensibility, without the cost or commitment of a permanent role. It ensures your IP evolves in step with your science, your data, and your business.

  • We provide senior‑level oversight and decision‑making that early and growth‑stage life‑science companies typically lack:

    • Strategic direction for patents, trade secrets, data exclusivity, and regulatory protection

    • Oversight of external patent counsel and alignment of their work with business priorities

    • IP input into scientific, clinical, and regulatory planning

    • Ownership and inventorship management across universities, CROs, and collaborators

    • Risk assessment and mitigation across partnerships, licensing, and transactions

    • Preparation for investor, partner, or acquirer due diligence

    • Internal processes for invention capture, confidentiality, and documentation

    It’s the leadership layer that ensures your IP is coherent, defensible, and investor‑ready.

  • Fractional leadership is flexible, tailored, and designed to integrate seamlessly with your team:

    • Regular strategic sessions with founders, CSOs, and scientific experts

    • Hands‑on review of filings, data and competitive intelligence

    • Coordination with external counsel to ensure quality, efficiency, and alignment

    • Clear prioritisation of IP actions based on commercial impact

    • Support during partnering discussions, negotiations, and diligence

    • Practical, founder‑friendly communication without jargon

    You get senior expertise, without the overhead or operational burden of building an internal IP function too early.

  • This support is most valuable when you are:

    • Moving from discovery into preclinical development

    • Preparing for a financing round or strategic partnership

    • Managing multiple external collaborators (universities, CDMOs, CROs, consultants)

    • Generating data that could form the basis of new filings

    • Scaling your pipeline or expanding into new modalities

    • Lacking internal IP leadership but needing strategic oversight

    • Preparing for due diligence or a transaction

    Fractional leadership ensures your IP decisions are timely, coordinated, and aligned with your scientific and commercial trajectory.

Work with us
Fractional IP leadership, interim Head of IP, Head of IP on demand, Patent Attorney on demand for biotech and pharma. Part-time european patent attorney. Black and white photo of a rowing team in a boat on the water, viewed from above.